BDX vs ERNA · P/E 34, rev $21.84B vs P/E 0.0, rev $582.0K
Becton Dickinson and Company (BDX) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BDX and ERNA stock pages for the full models.
Not investment advice.